Europe Bronchiectasis Market - Industry Trends and Forecast to 2028

Segmentation

Short Description
Europe Bronchiectasis Market, By Disease Type (CF Bronchiectasis and Non-CF Bronchiectasis), Severity (Mild to Moderate and Moderate-to-Severe), Type (Diagnosis and Treatment), Drugs Type (Branded and Generics), Route of Administration (Oral, Parenteral and Inhalation), End User (Hospitals, Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe) Industry Trends and Forecast to 2028

Market Definition:
Bronchiectasis is a term derived from Greek word bronckos which means airways and ectasis means widening. It is a chronic lung condition which is defined as abnormal and irreversible dilation of the bronchi in which both the muscular and elastic tissues are destroyed due to short-term and long-term infection. The combination of these infections leads to one or both lungs damage. The damage site is diagnosed by high resolution computed tomography (HRCT) scan in which it shows that the larger airways are mostly affected and in the smaller airways, the disease are not scanned thats why some of the patients deals with symptoms for many years before the diagnosis.

Market Segmentation:
The bronchiectasis market is segmented on the basis of the disease type, severity, type, drugs type, route of administration, end user and distribution channel.
 On the basis of disease type, the bronchiectasis market is segmented into CF bronchiectasis and non-CF bronchiectasis
 On the basis of severity, the bronchiectasis market is segmented into mild to moderate and moderate-to-severe
 On the basis of type, the bronchiectasis market is segmented into diagnosis and treatment
 On the basis of drugs type, the bronchiectasis market is segmented into branded and generics
 On the basis of route of administration, the bronchiectasis market is segmented into oral, parenteral and inhalation
 On the basis of end user, the bronchiectasis market is segmented into hospitals, clinics, home healthcare and others
 On the basis of distribution channel, the bronchiectasis market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others

Market Players
The key market players for Europe bronchiectasis market are listed below:
 Abbott
 HERSILL
 Indogen, Inc.
 Boehringer Ingelheim International GmbH
 Medline Industries, Inc.
 Ache Laboratories Farmaceuticos S.A.
 Horizon Therapeutics plc
 Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
 Trudell Medical International
 GlaxoSmithKline plc
 AstraZeneca
 Pfizer Inc.
 Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)
 Novartis AG
 Sun Pharmaceutical Industries Ltd.
 Bayer AG
 Dr. Reddys Laboratories Ltd.
 Sunovion Pharmaceuticals Inc. (a subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
 Viatris Inc.
 Covis Pharma
 Cipla Inc.

Methodology